Neurocrine Biosciences (NBIX) Total Debt Growth (1y) (2023)

Neurocrine Biosciences (NBIX) Total Debt Growth (1y) (2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt Growth (1y) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -0.14%
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 37.52%
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -92.65%
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -9.19%
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 0.63%
10 Liquidia 5.64 Bn 5.42 Bn 121.79 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2023 0.41%
Sep 30, 2023 0.41%